Want to join the conversation?
$BSX said that it is increasing 2016 adjusted operating margin guidance to 24.0-24.5%. With the exception of the 3% decline in the Cardiac Rhythm Management sales, all of the other businesses delivered strong organic growth led by Endo at 11%, Urology and Public Health at 12%, Interventional Cardiology at 13% and Peripheral Interventions at 14%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?